Evofem Biosciences, Inc.EVFMOTCMARKET
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank67
3Y CAGR-50.0%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-50.0%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 2.39 | +0.8% |
| 2023 | 2.37 | -44.7% |
| 2022 | 4.28 | -77.5% |
| 2021 | 19.06 | -95.2% |
| 2020 | 395.37 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |
| 2015 | 0.00 | - |